Ron Bentsur - Feb 10, 2022 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
Chairman & CEO, Director
Signature
/s/ Ron Bentsur
Stock symbol
NVCT
Transactions as of
Feb 10, 2022
Transactions value $
$53,890
Form type
4
Date filed
2/11/2022, 08:15 AM
Previous filing
Feb 8, 2022
Next filing
Feb 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock, par value $0.00001 Purchase $53.9K +8.5K +0.3% $6.34 2.81M Feb 10, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the weighted average purchase price. The range of prices for the shares purchased was $6.27 to $6.35. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.
F2 Includes 96,759 shares of restricted stock.